Area of research
Pharmacology · Cellular and Molecular Neuroscience
Research interest
Research interests include Treatment of Major Depression, Neurotransmitter Receptor Influence on Behavior, Tryptophan and brain disorders, and Genetic Associations and Epidemiology.
Effect of cytochrome CYP2C19 metabolizing activity on antidepressant response and side effects: Meta-analysis of data from genome-wide association studies
Pharmacogenetics of antidepressant response: A polygenic approach
New insights into the pharmacogenomics of antidepressant response from the GENDEP and STAR*D studies: rare variant analysis and high-density imputation
Exploring the role of drug-metabolising enzymes in antidepressant side effects
Common Genetic Variation and Antidepressant Efficacy in Major Depressive Disorder: A Meta-Analysis of Three Genome-Wide Pharmacogenetic Studies
Genetic differences in cytochrome P450 enzymes and antidepressant treatment response
SELF-REPORT AND CLINICIAN-RATED MEASURES OF DEPRESSION SEVERITY: CAN ONE REPLACE THE OTHER?
Genetic Predictors of Response to Serotonergic and Noradrenergic Antidepressants in Major Depressive Disorder: A Genome-Wide Analysis of Individual-Level Data and a Meta-Analysis
Estimating the heritability of reporting stressful life events captured by common genetic variants
Non-steroidal anti-inflammatory drugs and efficacy of antidepressants in major depressive disorder
Dissecting the Genetic Heterogeneity of Depression Through Age at Onset